PANACEA BIOTEC LTD. - 531349 - Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30, 2021
In continuation to our letter dated November 02, 2021 and pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. November 12, 2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and half year ended September 30, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on November 12, 2021. The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 05:15 P.M. We request you to kindly bring the above information to the notice of your members12-11-2021